Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:37:09 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



News for U:DMAC from 2023-05-09 to 2024-05-08 - 30 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 08:55U:DMACNews ReleaseDiaMedica Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update May 9, 2024
2024-04-17 16:08U:DMACNews ReleaseDiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
2024-04-04 16:30U:DMACSEDAR Annual ReportSEDAR Annual Report
2024-03-19 17:51U:DMACSEDAR Annual ReportSEDAR Annual Report
2024-03-19 17:44U:DMACSEDAR Audited Annual Financial StatementsSEDAR MD & A
2024-03-19 16:15U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
2024-01-29 16:13U:DMACNews ReleaseDiaMedica Therapeutics Announces Poster Presentation at International Stroke Conference
2024-01-22 08:23U:DMACNews ReleaseDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer
2023-11-13 19:42U:DMACSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-13 19:41U:DMACSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-13 16:28U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
2023-11-09 08:25U:DMACNews ReleaseDiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023
2023-11-06 08:23U:DMACNews ReleaseDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023
2023-09-12 08:13U:DMACNews ReleaseDiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer
2023-09-06 08:35U:DMACNews ReleaseDiaMedica Therapeutics to Participate at Lake Street ¢ € ™s 7th Annual Best Ideas Growth Conference
2023-08-14 17:07U:DMACSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-14 16:13U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
2023-08-08 08:32U:DMACNews ReleaseDiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023
2023-07-18 11:27U:DMACSEDAR Early Warning ReportSEDAR Early Warning Report
2023-07-18 08:30U:DMACNews ReleaseDiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference
2023-07-11 14:51U:DMACSEDAR Final ProspectusSEDAR Final Prospectus
2023-06-27 20:51U:DMACSEDAR Early Warning ReportSEDAR Early Warning Report
2023-06-27 11:43U:DMACSEDAR Early Warning ReportSEDAR Early Warning Report
2023-06-27 11:40U:DMACSEDAR Early Warning ReportSEDAR Early Warning Report
2023-06-26 08:30U:DMACNews ReleaseDiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement
2023-06-21 08:39U:DMACNews ReleaseDiaMedica Therapeutics Announces $37.5 Million Private Placement
2023-06-21 08:15U:DMACNews ReleaseDiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
2023-05-30 08:29U:DMACNews ReleaseDiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors
2023-05-16 13:01U:DMACSEDAR Interim Financial StatementsSEDAR MD & A
2023-05-15 16:28U:DMACNews ReleaseDiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results